Document is current
Any future updates will be listed below
-
Authors
Girotra, Mukul
Chiang, Yi-Hsuan https://orcid.org/0009-0005-0683-0149
Charmoy, Melanie
Ginefra, Pierpaolo https://orcid.org/0000-0003-3254-1269
Hope, Helen Carrasco https://orcid.org/0000-0001-5583-4510
Bataclan, Charles https://orcid.org/0009-0009-1880-8538
Yu, Yi-Ru https://orcid.org/0000-0002-3562-3502
Schyrr, Frederica https://orcid.org/0000-0002-9904-8316
Franco, Fabien
Geiger, Hartmut
Cherix, Stephane
Ho, Ping-Chih
Naveiras, Olaia
Auwerx, Johan https://orcid.org/0000-0002-5065-5393
Held, Werner
Vannini, Nicola https://orcid.org/0000-0002-6351-7512
- License Information
-
More Information
Article History
Received: 8 September 2021
Accepted: 24 July 2023
First Online: 31 August 2023
Competing interests
: J.A. is a scientific advisor to Amazentis, a company that develops UA as a therapeutic agent. Some elements of this work are part of patent no. 19152437.0 of which N.V. and M.G. are inventors. The remaining authors declare no competing interests.
